Morepen Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	688.26	273.81	169.45	216.66	158.03
Short-Term Investments	228.73	778.07	-	-	-
Cash & Short-Term Investments	916.99	1,052	169.45	216.66	158.03
Cash Growth	-12.82%	520.76%	-21.79%	37.10%	-61.82%
Accounts Receivable	3,331	3,248	3,249	2,632	2,506
Other Receivables	-	23.23	63.51	26.03	31.57
Receivables	3,336	3,276	3,315	2,661	2,541
Inventory	2,718	3,000	2,486	2,289	2,759
Prepaid Expenses	-	691.33	100.71	45.3	21.21
Other Current Assets	4,665	3,575	2,819	2,350	1,864
Total Current Assets	11,636	11,594	8,890	7,562	7,343
Property, Plant & Equipment	4,156	3,703	2,377	1,840	1,608
Long-Term Investments	1,013	71.74	13.01	-	-
Goodwill	-	744.74	744.74	744.74	744.74
Other Intangible Assets	1,190	720.43	196.68	254.99	306.77
Other Long-Term Assets	1,366	945.59	710.26	702.95	697.5
Total Assets	19,361	17,781	12,932	11,105	10,701
Accounts Payable	3,172	3,633	2,950	2,269	2,581
Accrued Expenses	-	278.81	291.46	250.44	207.37
Short-Term Debt	-	460.36	234.91	231.8	161.32
Current Portion of Long-Term Debt	610.9	75.99	21.44	10.51	1,158
Current Portion of Leases	89.04	122.18	-	-	-
Current Income Taxes Payable	-	101.27	166	79.6	101.51
Other Current Liabilities	1,031	334.9	356.36	370.5	355.53
Total Current Liabilities	4,903	5,007	4,020	3,212	4,565
Long-Term Debt	1,336	257.58	33.64	9.34	13.21
Long-Term Leases	42.61	134.84	-	-	-
Pension & Post-Retirement Benefits	-	298.97	265.93	225.66	208.69
Long-Term Deferred Tax Liabilities	164.59	69.77	22.5	26.86	24.83
Other Long-Term Liabilities	444.08	143.73	117.28	106.99	108.22
Total Liabilities	6,890	5,911	4,460	3,580	4,920
Common Stock	1,096	1,096	1,022	1,022	955.59
Additional Paid-In Capital	-	5,532	3,698	3,698	2,318
Retained Earnings	-	4,042	2,862	1,900	1,513
Comprehensive Income & Other	11,369	892.92	890.39	908.8	998.61
Total Common Equity	12,464	11,562	8,472	7,529	5,786
Minority Interest	6.51	307.27	-	-4.6	-4.61
Shareholders' Equity	12,471	11,870	8,472	7,524	5,781
Total Liabilities & Equity	19,361	17,781	12,932	11,105	10,701
Total Debt	2,079	1,051	289.99	251.64	1,332
Net Cash (Debt)	-1,162	0.93	-120.54	-34.98	-1,174
Net Cash Per Share	-2.12	0.00	-0.24	-0.07	-2.26
Filing Date Shares Outstanding	562.31	547.95	511.17	511.17	477.83
Total Common Shares Outstanding	562.31	547.95	511.17	511.17	477.83
Working Capital	6,733	6,587	4,870	4,350	2,778
Book Value Per Share	22.17	21.10	16.57	14.73	12.11
Tangible Book Value	11,275	10,097	7,531	6,529	4,734
Tangible Book Value Per Share	20.05	18.43	14.73	12.77	9.91
Land	-	232.69	14.33	14.33	14.33
Buildings	-	1,123	996.08	908.72	814.08
Machinery	-	4,568	3,736	4,036	3,804
Construction In Progress	-	283.41	244.52	170.14	141.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.